News | September 07, 2023
Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Eris Lifesciences enters into term loan agreement with Citi Bank
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
CiplaMed 2.0 leverages advanced analytics and automation
Subscribe To Our Newsletter & Stay Updated
